Genmab A/S (LON:0MGB)
London · Delayed Price · Currency is GBP · Price in DKK 2,011.50
-4.89 (-0.24%)
At close: Dec 18, 2025
Genmab Market Cap
Genmab has a market cap or net worth of 14.87 billion as of December 19, 2025. Its market cap has increased by 37.30% in one year.
Market Cap
14.87B
Enterprise Value
12.43B
Revenue
2.86B
Ranking
n/a
PE Ratio
12.62
Stock Price
2,011.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 287.00M to 14.87B, an increase of 5,079.47%. That is a compound annual growth rate of 16.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 14.87B | 40.98% |
| Dec 30, 2024 | 10.54B | -35.66% |
| Dec 29, 2023 | 16.39B | -28.50% |
| Dec 30, 2022 | 22.92B | 18.07% |
| Dec 30, 2021 | 19.41B | -0.78% |
| Dec 30, 2020 | 19.57B | 77.54% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| HSBC Holdings | 200.10B |
| Shell | 154.88B |
| Unilever | 108.28B |
| Rio Tinto Group | 99.46B |
| Rolls-Royce Holdings | 97.94B |
| British American Tobacco p.l.c. | 92.05B |
| GSK plc | 73.11B |